Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Researchers confirm two new prognostic markers for triple negative breast cancer

Researchers confirm two new prognostic markers for triple negative breast cancer

New method can deliver chemotherapy drugs directly to malignant cells

New method can deliver chemotherapy drugs directly to malignant cells

Cardiac resynchronization therapy improves heart function in cancer survivors

Cardiac resynchronization therapy improves heart function in cancer survivors

Drugs can be safely delivered to cancerous lymph nodes using sound waves

Drugs can be safely delivered to cancerous lymph nodes using sound waves

New technology allows delivery of drugs directly to cancer cells

New technology allows delivery of drugs directly to cancer cells

Nanotechnology enhances delivery of chemotherapy drugs

Nanotechnology enhances delivery of chemotherapy drugs

UCLA researchers identify new drug delivery pathway to stop tumor growth

UCLA researchers identify new drug delivery pathway to stop tumor growth

New study identifies potential enzyme target for diabetic retinopathy

New study identifies potential enzyme target for diabetic retinopathy

Psoriasis drug could be repurposed to treat osteosarcoma

Psoriasis drug could be repurposed to treat osteosarcoma

Cancer cells survive chemotherapy by eating their neighboring tumor cells

Cancer cells survive chemotherapy by eating their neighboring tumor cells

A 'homing beacon' for cancer drugs

A 'homing beacon' for cancer drugs

Patients with advanced Hodgkin's lymphoma may benefit from radiotherapy after chemotherapy

Patients with advanced Hodgkin's lymphoma may benefit from radiotherapy after chemotherapy

Study finds no statistically significant effect of drug shortages on cancer treatment

Study finds no statistically significant effect of drug shortages on cancer treatment

A very old antibiotic shows promise in treating fatal form of breast cancer

A very old antibiotic shows promise in treating fatal form of breast cancer

Early marker of cardiac damage triggered by cancer treatment identified

Early marker of cardiac damage triggered by cancer treatment identified

New breakthrough study can impact drug development and personalized medicine

New breakthrough study can impact drug development and personalized medicine

New study compares chemotherapy drugs with development of cardiomyopathy

New study compares chemotherapy drugs with development of cardiomyopathy

Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs

Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs

Study uncovers how tumors backfire on neoadjuvant chemotherapy

Study uncovers how tumors backfire on neoadjuvant chemotherapy

Soyasapogenol B: A new drug delivery technology for therapeutics

Soyasapogenol B: A new drug delivery technology for therapeutics